Treatment and preventions of asthma

Traitement et preventions de l'asthme


The invention provides compositions and methods for treating asthmatic conditions. Such compositions and methods utilize a lung surfactant mixture comprising a lung surfactant polypeptide.
L'invention concerne des compositions et des procédés permettant de traiter des conditions asthmatiques. Ces compositions et ces procédés utilisent un mélange tensioactif pulmonaire contenant un polypeptide tensioactif pulmonaire.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (1)

    Publication numberPublication dateAssigneeTitle
    WO-0027360-A1May 18, 2000Byk Gulden Lomberg Chemische Fabrik GmbhAppareil de traitement contenant des compositions a base de surfactants pulmonaires

NO-Patent Citations (1)

    See also references of EP 1694314A1

Cited By (23)

    Publication numberPublication dateAssigneeTitle
    EP-2292215-A3August 01, 2012Discovery Laboratories, Inc.Procédés de production de formulations tensioactives du poumon par lyophilisation, formulations et leurs utilisations
    EP-2382978-A2November 02, 2011Erasmus University Medical Center RotterdamModulation of the immune system by inositol phospholipids
    JP-2009539826-ANovember 19, 2009エラスムス ユニバーシティ メディカル センター ロッテルダムイノシトールリン脂質による免疫系の調節
    JP-2010503731-AFebruary 04, 2010ディスカバリー ラボラトリーズ,インコーポレイテッド肺サーファクタント製剤および粘液クリアランスの促進方法
    JP-WO2007001094-A1January 22, 2009相男 李, 相男 李, 浩 雪竹, 浩 雪竹人工肺サーファクタント組成物
    US-7582312-B2September 01, 2009Discovery Laboratories, Inc.Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
    US-8221772-B2July 17, 2012Discovery Laboratories Inc.Pulmonary surfactant formulations and methods for promoting mucus clearance
    US-8785390-B2July 22, 2014Alphabeta AbMethods for treatment of Alzheimer's disease
    US-8785391-B2July 22, 2014Alphabeta AbCompound and method for treatment of alzheimer's disease and familial dementia
    US-9289388-B2March 22, 2016Paka Pulmonary Pharmaceuticals, Inc.Methods and compositions for delivery of medicaments to the lungs
    US-9402883-B2August 02, 2016Alphareta AbCompound and method for treatment of Alzheimer's disease
    US-9522170-B2December 20, 2016Alphabeta AbMethods of screening compounds for the fibril formation of Aβ peptides based on a decreased trimer/monomer ratio of a chaperone protein
    WO-2005073246-A2August 11, 2005Discovery Laboratories, Inc.Methode de preparation d'un surfactant pulmonaire kl4
    WO-2005073246-A3June 15, 2006Discovery Lab Inc, Ralph Niven, Naina PatelMethod for preparing kl4 lung surfactant
    WO-2006055532-A2May 26, 2006Discovery Laboratories, Inc.Procedes de production de formulations de tensioactifs pulmonaires par lyophilisation et formulations et utilisations correspondantes
    WO-2006055532-A3April 19, 2007Roy Coe, Discovery Lab Inc, Mark JohnsonProcedes de production de formulations de tensioactifs pulmonaires par lyophilisation et formulations et utilisations correspondantes
    WO-2007005672-A2January 11, 2007The Scripps Research InstituteTraitement et prevention de maladies et de situations respiratoires
    WO-2007005672-A3May 10, 2007Charles G Chochrane, Scripps Research InstTreatment and prevention of respiratory diseases and conditions
    WO-2007142510-A1December 13, 2007Erasmus University Medical Center RotterdamModulation du système immunitaire par des phospholipides d'inositol
    WO-2008151235-A2December 11, 2008Forma Therapeutics, Inc.Compositions for delivering medicaments into the lungs, uses thereof
    WO-2008151235-A3March 26, 2009Forma Therapeutics Inc, Frank GuarnieriProcédés et compositions pour administrer des médicaments aux poumons
    WO-2010087771-A1August 05, 2010Alphabeta AbComposé et procédé de traitement de la maladie d'alzheimer
    WO-2013081452-A1June 06, 2013Erasmus University Medical Center RotterdamPhosphatidylinositol